S100B and LDH as early prognostic markers for response and overall survival in melanoma patients treated with anti-PD-1 or combined anti-PD-1 plus anti-CTLA-4 antibodies

DSpace Repository

S100B and LDH as early prognostic markers for response and overall survival in melanoma patients treated with anti-PD-1 or combined anti-PD-1 plus anti-CTLA-4 antibodies

Author: Wagner, Nikolaus B.; Forschner, Andrea; Leiter, Ulrike; Garbe, Claus; Eigentler, Thomas K.
Tübinger Autor(en):
Wagner, Nikolaus B.
Forschner, Andrea Lydia
Leiter-Stöppke, Ulrike Martina Barbara
Garbe, Claus
Eigentler, Thomas Kurt
Published in: British Journal of Cancer (2018), Bd. 119, H. 3, S. 339-346
Verlagsangabe: Nature Publishing Group
Language: English
Full text: http://dx.doi.org/10.1038/s41416-018-0167-x
ISSN: 1532-1827
DDC Classifikation: 610 - Medicine and health
Dokumentart: Artikel
Show full item record

This item appears in the following Collection(s)